Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objectives: Evaluation of the clinical long-term safety, tolerability, patient satisfaction,
pharmacokinetics and pattern of use of oral prucalopride tablets given in doses up to 4 mg
once daily to patients with chronic constipation